Although pyramidal signs were described in a subset of patients (pyramidal signs without manifest spasticity in 3/10 patients27), the overall ADSA phenotype bears little resemblance to the RNF170-associated HSP we describe here. This evidence concerns the gene RNF170 and hereditary spastic paraplegia.